Oncology
Clinical research at the Universita Degli Studi Di Padova includes solid tumours with a strong focus on breast cancer, particularly triple negative breast cancer, alongside non small cell lung cancer.
- Triple negative breast cancer
- Non small cell lung cancer
- Breast cancer
Research interests in this area include immune checkpoint inhibitor support, adjuvant immunotherapy, and treatment strategies for high-risk disease after curative-intent therapy.
Immuno-oncology
The sponsor funds studies examining the interaction between immunotherapy and other treatment approaches in cancer, with attention to enhancing outcomes in triple negative breast cancer and non small cell lung cancer.
- Immune checkpoint inhibitors
- Adjuvant anti-PD-L1 therapy
- Treatment response modulation
These trials reflect interest in PD-L1-directed strategies and the use of supportive agents alongside cancer immunotherapy.
Cardiology
Another active area is chronic heart failure, with research centred on symptom control and supportive treatment for patients with heart failure.
- Chronic heart failure
- Heart failure symptoms
- Clinical management of iron deficiency
The sponsor also explores treatment combinations relevant to patients with cardiac dysfunction and overlapping nutritional deficiencies.
Iron deficiency and nutritional support
Studies funded by the sponsor include management of iron deficiency in the setting of chronic heart failure, with interest in oral and intravenous iron replacement approaches and related supportive care.
- Iron deficiency
- Oral iron supplementation
- Vitamin D
This area links micronutrient replacement with cardiovascular symptom improvement and broader supportive treatment in chronic disease.
